Jury awards Nektar $90M in suit against Lilly
Nektar Therapeutics won $90 million in its lawsuit against Eli Lilly over a fractured licensing deal, a win for the biotech but a far smaller sum than was sought. Jurors in the US District Court ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.